Gen Digital Inc. engages in the provision of cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers security and performance products under Norton, Avast, Avira, AVG, and CCleaner brands that provide real-time protection and maintenance for PCs, Macs, and mobile devices against malware, viruses, adware, and other online threats. It also provides identity protection solutions, including LifeLock Identity Theft Protection, Avast and AVG Secure Identity, Norton Identity Theft Protection, and Dark Web Monitoring for monitoring of credit reports, financial accounts, the dark web, and social media accounts to help safeguard customers' personal information. In addition, the company offers Virtual Private Network (VPN) solutions under Norton, Avast and AVG brands to enhance security and online privacy that allows customers to securely transmit and access private information, such as passwords, bank details, and credit card numbers, when using public Wi-Fi on PCs, Macs, and mobile iOS and Android devices; AntiTrack and Secure Browser products which helps to keep personal information and browsing activity anonymous while browsing online; and Privacy Monitor Assistant and BreachGuard products for removing customers' data from public data broker sites; and ReputationDefender, a white glove service that helps customers manage all aspects of their personal branding online, including search results, social media sites, and overall web presence. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Gen Digital Inc.

NervGen Pharma ( ($NGEN) ) has provided an update. On May 26, 2026, NervGen Pharma reported independently conducted, blinded biomechanical gait ana...

NervGen Reports Objective Neural Recovery Signal for NVG-291 in Chronic SCI Ahead of Phase 3

Qiagen ( ($QGEN) ) has provided an update. QIAGEN disclosed that the Dutch financial regulator AFM has notified the company of a substantial shareh...

Norges Bank Discloses 2.44% Stake in QIAGEN

Legal & General ( ($GB:LGEN) ) has shared an announcement. Legal & General Group has repurchased 12,578,843 ordinary shares between 18 and 22 May 2...

Legal & General Cancels 12.6 Million Shares Under Ongoing Buyback

FTSE Russell has released its preliminary changes for the Russell 3000 Index ahead of the official rebalancing on June 26, putting several healthca...

5 Healthcare Stocks Set to Join the Russell 3000

In a report released today, from J.P. Morgan reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released today, B...

Genuit Group (GEN) Receives a Buy from J.P. Morgan

In a report released today, from Deutsche Bank reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released today,...

Genuit Group (GEN) Gets a Buy from Deutsche Bank

In a report released today, from Berenberg Bank reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released on Ma...

Genuit Group (GEN) Gets a Buy from Berenberg Bank

G5 Entertainment AB ( ($SE:G5EN) ) has issued an announcement. G5 Entertainment AB has issued a corrected notice for its Annual General Meeting sch...

G5 Entertainment Corrects AGM Notice, Restores CEO Share Allocation Level

Stifel Nicolaus analyst Justin Keywood reiterated a Buy rating on NervGen Pharma on May 21 and set a price target of $6.00. Keywood covers the Heal...

NervGen Pharma (NGEN) Receives a Buy from Stifel Nicolaus

In a report released on May 22, Priyal Woolf from Jefferies maintained a Buy rating on Genuit Group, with a price target of p388.00. The company’s ...

Jefferies Keeps Their Buy Rating on Genuit Group (GEN)

J.P. Morgan analyst maintained a Buy rating on Genuit Group on May 22 and set a price target of p440.00. The company’s shares closed last Friday at...

Genuit Group (GEN) Gets a Buy from J.P. Morgan

Peel Hunt analyst Sam Cullen maintained a Buy rating on Genuit Group on May 22 and set a price target of p360.00. The company’s shares closed last ...

Genuit Group (GEN) Gets a Buy from Peel Hunt

Gen Digital Inc. (GEN) has disclosed a new risk, in the Technology category. Gen Digital Inc. faces rising risk as it embeds AI and generative AI a...

Gen Digital’s AI Ambitions Face Mounting Legal, Regulatory and Cost Risks

Qiagen ( ($QGEN) ) has issued an announcement. Qiagen has disclosed a change in its shareholder structure after the Dutch financial regulator AFM n...

Norges Bank Discloses 3.07% Stake in Qiagen

Qiagen ( ($QGEN) ) has issued an update. QIAGEN has disclosed that the Dutch financial regulator AFM notified the company of a substantial sharehol...

BlackRock Discloses Significant Stake in Qiagen

Qiagen ( ($QGEN) ) has provided an update. The Netherlands Authority for the Financial Markets has notified Qiagen N.V. that UBS Group AG has repor...

UBS Group Discloses 2.87% Voting Stake in Qiagen

Qiagen ( ($QGEN) ) has provided an announcement. Qiagen has disclosed that the Dutch financial markets regulator AFM notified the company of a subs...

Qiagen discloses UBS’s 3.15% stake following AFM notification

NervGen Pharma ( ($NGEN) ) has shared an announcement. On May 21, 2026, NervGen Pharma announced it had commenced an underwritten public offering o...

NervGen Pharma Launches Underwritten Public Offering to Fund NVG-291 Development

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Amkor (AMKR) and Gen Digital (GEN) with bullish sent...

Analysts Offer Insights on Technology Companies: Amkor (AMKR) and Gen Digital (GEN)

Genuit Group ( ($GB:GEN) ) just unveiled an update. Genuit Group plc said all resolutions at its 22 May annual general meeting in Leeds were approv...

Genuit shareholders back all AGM resolutions and approve 8.7p dividend

Genuit Group ( ($GB:GEN) ) has shared an announcement. Genuit Group reported that group revenue for the four months to 30 April 2026 was broadly fl...

Genuit holds revenue steady amid cost pressures and eyes structural growth

Legal & General ( ($GB:LGEN) ) has provided an update. Legal & General shareholders approved all resolutions at the company’s Annual General Meetin...

Legal & General Wins Strong Investor Backing at AGM and GM

The latest announcement is out from Qiagen ( ($QGEN) ). QIAGEN N.V. disclosed that The Stephen H. Rusckowski Living Trust, associated with a member...

QIAGEN Discloses Million-Dollar Insider Share Purchase by Supervisory Board Member Trust

An announcement from Legal & General ( ($GB:LGEN) ) is now available. Legal & General Group Plc disclosed that its Group Chief Risk Officer, Chris ...

Legal & General Discloses Share Sale by Chief Risk Officer

The latest announcement is out from Gencor ( ($GENC) ). On May 14, 2026, Gencor Industries, Inc. announced that Chief Financial Officer and Treasur...

Gencor Announces Upcoming Retirement of Chief Financial Officer

Tecogen Inc (($TGEN)) has held its Q1 earnings call. Read on for the main highlights of the call. Tecogen’s latest earnings call struck a cautious ...

Tecogen Earnings Call Balances Strain With Promise

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compugen (CGEN) and TriSalus Life Sciences (TLSI) wi...

Analysts’ Top Healthcare Picks: Compugen (CGEN), TriSalus Life Sciences (TLSI)

The latest update is out from Oragenics ( ($OGEN) ). On May 18, 2026, Oragenics issued a press release providing an update to its shareholders, und...

Oragenics Highlights Investor Outreach at Micro-Cap Conference

Qiagen ( ($QGEN) ) has shared an announcement. Qiagen has reported that the Netherlands Authority for the Financial Markets (AFM) notified the comp...

Bank of America Discloses 2.98% Stake in Qiagen via AFM Filing

The latest update is out from Legal & General ( ($GB:LGEN) ). Legal & General has repurchased 24,290,384 of its ordinary shares between 11 and 15 M...

Legal & General Cancels 24.3 Million Shares in Ongoing Buyback

In a report released today, Larissa Van Deventer from Barclays maintained a Buy rating on Legal & General, with a price target of £3.40. According ...

Barclays Sticks to Their Buy Rating for Legal & General (LGEN)

NervGen Pharma ( ($NGEN) ) has shared an update. On May 15, 2026, NervGen Pharma filed a Form 6-K for May 2026 with the U.S. Securities and Exchang...

NervGen Pharma Narrows Quarterly Loss but Cash Reserves Decline in Q1 2026 Filing

Agenus ( ($AGEN) ) has shared an update. On May 12, 2026, Agenus Inc. disclosed that its Senior Director of Financial Reporting and Compliance and ...

Agenus Announces Resignation of Principal Accounting Officer

In a report released today, Priyal Woolf from Jefferies reiterated a Buy rating on Genuit Group, with a price target of p388.00. According to TipRa...

Jefferies Sticks to Its Buy Rating for Genuit Group (GEN)

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Wolverine World Wide (WWW) and GEN Restaurant...

Analysts Are Bullish on Top Consumer Cyclical Stocks: Wolverine World Wide (WWW), GEN Restaurant Group, Inc. Class A (GENK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Cardiff Oncology (CRDF) and Meiragt...

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Cardiff Oncology (CRDF) and Meiragtx Holdings (MGTX)

There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Tecogen (TGEN) and Kornit Digital (KRNT) with ...

Analysts Offer Insights on Industrial Goods Companies: Tecogen (TGEN) and Kornit Digital (KRNT)

In a report released yesterday, from Jefferies reiterated a Hold rating on Foresight Environmental Infrastructure Limited GBP. The company’s shares...

Jefferies Keeps Their Hold Rating on Foresight Environmental Infrastructure Limited GBP (FGEN)

Compugen ($CGEN) announced an update on their ongoing clinical study. The Phase 1 study “A Phase 1 Study of The Safety and Tolerability of COM902 i...

Compugen’s COM902 Phase 1 Completion: What the Latest Trial Update Means for CGEN Investors

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General Group Plc has repurchased 16,869,889 ordinary shares between 5 ...

Legal & General Cancels 16.9 Million Shares in Ongoing Buyback

Wells Fargo analyst Richard Poland maintained a Hold rating on Gen Digital on May 8 and set a price target of $22.00. The company’s shares closed l...

Wells Fargo Reaffirms Their Hold Rating on Gen Digital (GEN)

Gen Digital Inc. (($GEN)) has held its Q4 earnings call. Read on for the main highlights of the call. Gen Digital Inc. delivered a decidedly upbeat...

Gen Digital Signals AI-Fueled Growth After Record Year

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Generate Biomedicines, Inc. today and set a price target of $24.00. Tenthoff cover...

Piper Sandler Sticks to Their Buy Rating for Generate Biomedicines, Inc. (GENB)

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on BCE (BCE) and Genius Sports Limited (GEN...

Analysts Offer Insights on Communication Services Companies: BCE (BCE) and Genius Sports Limited (GENI)

Guggenheim analyst reiterated a Hold rating on Repligen yesterday. The company’s shares closed yesterday at $126.43. In addition to Guggenheim, Rep...

Guggenheim Reaffirms Their Hold Rating on Repligen (RGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Qiagen (QGEN), Perrigo Company (PRGO) and Envista Ho...

Wall Street Analysts Are Bullish on Top Healthcare Picks

The latest announcement is out from Genius Sports Limited ( ($GENI) ). On May 7, 2026, Genius Sports Limited filed a Form 6-K reporting unaudited i...

Genius Sports Posts Higher Q1 2026 Revenue and Files Interim 6-K

Analysts have been eager to weigh in on the Healthcare sector with new ratings on ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC). ACA...

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)

In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Repligen, with a price target of $207.00. Arias covers the...

Repligen (RGEN) Gets a Buy from Stifel Nicolaus

The latest announcement is out from Genmin Ltd. ( ($AU:GEN) ). Genmin Limited has issued 2,250,000 fully paid ordinary shares without a prospectus ...

Genmin Issues 2.25 Million New Shares Under Corporations Act Exemption

The latest announcement is out from G5 Entertainment AB ( ($SE:G5EN) ). G5 Entertainment reported first-quarter 2026 revenue of USD 21.7m, down 11%...

G5 Entertainment Sees Revenue Dip but Margin Gains as Direct Sales and High-Value Users Grow

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Disc Medicine (IRON) and Cytokineti...

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Disc Medicine (IRON) and Cytokinetics (CYTK)

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General has disclosed that several senior executives and persons discharging m...

Legal & General Executives Acquire Shares Under Employee Plan

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General has repurchased 28,721,089 ordinary shares between 27 April and 1 May ...

Legal & General Cancels 28.7 Million Shares in Ongoing Buyback

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SOPHiA GENETICS (SOPH), CVRx (CVRX) and Repligen (RG...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN) and IQVIA Holdings (IQV) with bullis...

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN) and IQVIA Holdings (IQV)

Analysts have been eager to weigh in on the Technology sector with new ratings on KLA (KLAC), Uber Technologies (UBER) and Gen Digital (GEN). KLA (...

Analysts Conflicted on These Technology Names: KLA (KLAC), Uber Technologies (UBER) and Gen Digital (GEN)

The latest update is out from Legal & General ( ($GB:LGEN) ). Legal & General Group Plc disclosed a share transaction by its chair, Sir John Kingma...

Legal & General Chair Sir John Kingman Buys Shares in Company ISA Transaction

An update from Legal & General ( ($GB:LGEN) ) is now available. Legal & General has reported that, as at 30 April 2026, its share capital comprised...

Legal & General Updates Share Capital and Voting Rights After Buyback

Legal & General ( ($GB:LGEN) ) just unveiled an update. Legal & General Group Plc has admitted 137,479 new ordinary shares of £0.025 each to tradin...

Legal & General Adds Sharesave Scheme Stock to London Listing

Legal & General ( ($GB:LGEN) ) has provided an update. Legal & General has disclosed share purchases by non-executive directors Mark Jordy, Ric Lew...

Legal & General Discloses Routine Share Purchases by Non-Executive Directors

Genuit Group ( ($GB:GEN) ) just unveiled an update. Genuit Group plc disclosed that chief executive officer Joe Vorih has exercised a nil-cost opti...

Genuit CEO Increases Stake After Exercising Deferred Share Bonus Options

Genius Sports Limited ( ($GENI) ) has issued an update. On April 30, 2026, Genius Sports completed the acquisition of Zeal Ltd’s Legend business, a...

Genius Sports Closes Legend Acquisition and Secures $1.05 Billion Debt Package

There’s a lot to be optimistic about in the Communication Services sector as 3 analysts just weighed in on Genius Sports Limited (GENI), Shenandoah...

Analysts Are Bullish on Top Communication Services Stocks: Genius Sports Limited (GENI), Shenandoah Telecommunications Co (SHEN)

Genuit Group ( ($GB:GEN) ) has shared an announcement. Genuit Group plc has confirmed that as of 30 April 2026 it has 251,903,686 ordinary shares i...

Genuit Group Updates Total Voting Rights and Share Capital

Genuit Group ( ($GB:GEN) ) has provided an update. Genuit Group has disclosed that chief executive officer Joe Vorih and chief strategy and sustain...

Genuit Executives Exercise Long-Term Incentive Share Options

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General Group Plc has reported a share purchase by non-executive direct...

Legal & General Discloses Share Purchase by Non-Executive Director

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN) and BridgeBio Pharma (BBIO). Qiagen (QGEN) In a rep...

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and BridgeBio Pharma (BBIO)

Legal & General ( ($GB:LGEN) ) just unveiled an announcement. Legal & General has repurchased 19,361,337 of its ordinary shares between 20 and 24 A...

Market Cap	$16.55B	P/E Ratio	9.31
52W High	$32.22	52W Low	$17.78
Div Yield	50.0%	Payout Ratio	31.9%
EPS Growth 3Y	-10.3%	52W Position	48.4%
Overall Score	62	Value Score	85
Quality Score	47	Technical Score	54

EPS Current Est	$2.66	EPS Next Est	$2.95
EPS Growth Est	+10.9%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GEN	$24.76	-0.24%	6.44M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GEN	$24.76	-0.2%	6.44M
3
4
5
6

GEN

GEN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Gen Digital Inc. Data in Excel

Get Gen Digital Inc. Data in Excel